MAP Kinase Pathway Alterations in <i>BRAF</i> -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Cancer Discovery|2013Cited by 473
Data Supplement from MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Unknown|2023Cited by 0
Supplementary Figures from MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Unknown|2023Cited by 0
Supplementary Table 3 from MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Unknown|2023Cited by 0
Supplementary Table 4 from MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Unknown|2023Cited by 0